SCHEMBL29773630

SCHEMBL29773630

CNC(=S)N/N=C/c1ncc(F)c2ccccc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TOP2A P11388 1/20 0.52
▸ MEN1 O00255 2/20 0.51
▸ KMT2A Q03164 2/20 0.51
▸ LMNA P02545 5/20 0.45
▸ HTT P42858 4/20 0.45
▸ POLB P06746 1/20 0.45
▸ MAPT P10636 4/20 0.44
▸ ALOX12 P18054 3/20 0.44
▸ TDP1 Q9NUW8 2/20 0.44
▸ ALDH1A1 P00352 2/20 0.44
▸ NPSR1 Q6W5P4 3/20 0.44
▸ G6PD P11413 1/20 0.44
▸ NCOA3 Q9Y6Q9 2/20 0.43
▸ RECQL P46063 1/20 0.43
▸ RCE1 Q9Y256 1/20 0.43
▸ CTH P32929 1/20 0.42
▸ NCOA1 Q15788 1/20 0.41
▸ KDM4E B2RXH2 3/20 0.41
▸ GAA P10253 3/20 0.41
▸ NPC1 O15118 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29773619 0.84 TOP2A (0.48) TOP2AMEN1KMT2AMAPTALOX12
SCHEMBL29773614 0.84 TOP2A (0.48) TOP2AMEN1KMT2AMAPTALOX12
SCHEMBL29773633 0.84 NCOA3 (0.61) MEN1KMT2AHTTMAPTNPSR1
SCHEMBL29773638 0.77 NCOA3 (0.71) TOP2AMEN1KMT2ALMNAHTT
SCHEMBL29773635 0.74 NCOA3 (0.54) TOP2AMEN1KMT2ALMNAHTT
SCHEMBL29773628 0.74 NCOA3 (0.54) TOP2AMEN1KMT2ALMNAHTT
SCHEMBL29773620 0.74 NCOA3 (0.75) TOP2AMEN1KMT2ALMNAHTT
SCHEMBL29773641 0.74 NCOA3 (0.75) TOP2AMEN1KMT2ALMNAHTT
SCHEMBL29773615 0.71 NCOA3 (0.49) TOP2AMEN1KMT2ALMNAHTT
SCHEMBL13611503 0.69 TOP2A (1.00) TOP2AMEN1KMT2ALMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12528774-B2 Thiosemicarbazone compounds and uses thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2026-01-20 — — US disclosed
US-20220274929-A1 THIOSEMICARBAZONE COMPOUNDS AND USES THEREOF NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2022-09-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220274929-A1 THIOSEMICARBAZONE COMPOUNDS AND USES THEREOF TST, TPMT, ABCG2 TOP2A 183/4885MEN1 2719/4885KMT2A 1857/4885
US-12528774-B2 Thiosemicarbazone compounds and uses thereof SCN2B, SCN1B, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 TOP2A 266/4885MEN1 984/4885KMT2A 1518/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback